CIRCULATING BIOMARKERS THAT PREDICT RESPONSE TO AN IRREVERSIBLE PAN-HER KINASE INHIBITOR IN EGFR-AMPLIFIED GBM.

PI: Andrew S. Chi, M.D., Ph.D.
Divisions of Hematology/Oncology and Neuro-Oncology
Department of Neurology
Massachusetts General Hospital & Harvard Medical School

Close Menu